Screening compound: InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3

Screening compound: InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3
Screening compound: InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J026-4432

Molecular Formula

C21H23ClN4O3 (C21 H23 ClN4 O3)

Compound Name

3-[(4-chlorophenyl)methyl]-N,N-diethyl-1,7-dimethyl-2,4-dioxo-1H,2H,3H,4H-pyrido[2,3-d]pyrimidine-5-carboxamide

IUPAC name

3-[(4-chlorophenyl)methyl]-NN-diethyl-17-dimethyl-24-dioxo-1H2H3H4H-pyrido[23-d]pyrimidine-5-carboxamide

SMILES

CCN(CC)C(c1cc(C)nc(N(C)C(N2Cc(cc3)ccc3Cl)=O)c1C2=O)=O

InChI

InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3

InChI Key

PXASWFHMTTXRPG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27219964

InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GABA Library (7115 compounds)

Hsp90-Targeted Library (11355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3?
Check Price and Availability of InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H23ClN4O3/c1-5-25(6-2)19(27)16-11-13(3)23-18-17(16)20(28)26(21(29)24(18)4)12-14-7-9-15(22)10-8-14/h7-11H,5-6,12H2,1-4H3 available by request